XML 35 R24.htm IDEA: XBRL DOCUMENT v3.24.1.1.u2
Product Acquisitions And Return Of Product Rights (Tables)
3 Months Ended
Mar. 31, 2024
Business Combinations [Abstract]  
Schedule of Business Acquisitions by Acquisition, Contingent Consideration
The following table presents the changes in the fair value of the contingent consideration liability that is remeasured on a recurring basis. The contingent consideration earned and accrued in operating expenses is paid to Theravance quarterly.
Balance at December 31, 2023
$4,033,373 
Cash payment of royalty during the period(394,426)
Change in fair value of contingent consideration included in operating expenses28,072 
Contingent consideration earned and accrued in operating expenses— 
Balance at March 31, 2024
$3,667,019 
The following table presents the changes in the fair value of the contingent consideration liability that is remeasured on a recurring basis.
Balance at December 31, 2023$2,306,000 
Cash payment of milestones and royalty during the period(236,275)
Change in fair value of contingent consideration included in operating expenses(258,502)
Contingent consideration earned and accrued in operating expenses182,777 
Balance at March 31, 2024
$1,994,000